Met Life Investment Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 22,678 shares of TARS stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,678
Previous 21,504
5.46%
Holding current value
$1.17 Million
Previous $707,000
77.51%
% of portfolio
0.01%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TARS
# of Institutions
200Shares Held
40.4MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$169 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$167 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$131 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$129 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$117 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.38B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...